Status: Approved
Entry Type: Small molecule
Molecule Category: Parent

Indications

Mesh Heading Maximum Phase Reference
Cholangiocarcinoma Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Lymphoma, T-Cell Phase 1/Phase 2 ClinicalTrials
Thyroid Diseases; Thyroid Neoplasms Phase 2 ClinicalTrials
Esophageal Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2/Phase 3 ClinicalTrials
Sarcoma Phase 2 ClinicalTrials
Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasms, Squamous Cell Phase 2 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Sarcoma Phase 2 ClinicalTrials
Stomach Neoplasms Phase 1 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 3 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Melanoma Phase 2 ClinicalTrials
Uterine Cervical Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms Phase 2 ClinicalTrials
Uterine Cervical Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Colorectal Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 3 ClinicalTrials
Ascites Phase 2 ClinicalTrials
Breast Neoplasms; Carcinoma, Ovarian Epithelial; Ovarian Neoplasms; Triple Negative Breast Neoplasms Phase 1 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Melanoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Adenocarcinoma Phase 1 ClinicalTrials
Colorectal Neoplasms Phase 2 ClinicalTrials
Biliary Tract Neoplasms; Carcinoma Phase 2 ClinicalTrials
Pancreatic Neoplasms Phase 2 ClinicalTrials
Gestational Trophoblastic Disease Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Glioma Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 1/Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Neoplasms; Ovarian Neoplasms; Stomach Neoplasms Phase 4 ClinicalTrials
Adenocarcinoma; Adenocarcinoma of Lung Phase 2 ClinicalTrials
Glioma Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 4 ClinicalTrials
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma Phase 2 ClinicalTrials
Adenocarcinoma; Carcinoma, Transitional Cell; Neoplasms Phase 1/Phase 2 ClinicalTrials
Lymphoma; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral Phase 4 ClinicalTrials
Colorectal Neoplasms Phase 2 ClinicalTrials
Esophageal Neoplasms Phase 2 ClinicalTrials
Carcinoma; Liver Neoplasms Phase 2 ClinicalTrials
Esophageal Neoplasms Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Adenocarcinoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Stomach Neoplasms Phase 3 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 3 ClinicalTrials
Stomach Neoplasms Phase 3 ClinicalTrials
Adenocarcinoma Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 1/Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Squamous Cell Phase 4 ClinicalTrials
Adenocarcinoma Phase 1 ClinicalTrials
Pancreatic Neoplasms Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Colorectal Neoplasms Phase 3 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular; Stomach Neoplasms Phase 1/Phase 2 ClinicalTrials
Bile Duct Neoplasms; Carcinoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma Phase 2 ClinicalTrials
Stomach Neoplasms Phase 3 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 3 ClinicalTrials
Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasms, Squamous Cell Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Lung Neoplasms Phase 2 ClinicalTrials
Adenocarcinoma; Adenocarcinoma of Lung Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Signet Ring Cell; Stomach Neoplasms Phase 3 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma Phase 1 ClinicalTrials
Thyroid Diseases; Thyroid Neoplasms Phase 2 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Neoplasm Metastasis; Osteosarcoma Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 3 ClinicalTrials
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse Phase 4 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 3 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Osteosarcoma; Sarcoma Phase 2 ClinicalTrials
Breast Neoplasms Phase 2/Phase 3 ClinicalTrials
Neoplasms; Stomach Neoplasms Phase 2 ClinicalTrials
Adenocarcinoma; Adenocarcinoma of Lung Phase 2 ClinicalTrials
Adenocarcinoma; Stomach Neoplasms Phase 1/Phase 2 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Stomach Neoplasms Phase 4 ClinicalTrials
Drug-Related Side Effects and Adverse Reactions Phase 4 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Esophageal Neoplasms; Metaplasia Phase 2/Phase 3 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Head and Neck Neoplasms Phase 2 ClinicalTrials
Esophageal Neoplasms; Recurrence Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasm Metastasis; Neoplasms, Second Primary; Recurrence Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2/Phase 3 ClinicalTrials
Adenocarcinoma Phase 2 ClinicalTrials
Cholangiocarcinoma Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Neoplasm Metastasis; Osteosarcoma Phase 2/Phase 3 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2/Phase 3 ClinicalTrials
Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Carcinoma; Nasopharyngeal Carcinoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Adenoid Cystic Phase 2 ClinicalTrials
Ovarian Neoplasms Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Renal Cell Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Osteosarcoma Phase 2 ClinicalTrials
Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma Phase 2 ClinicalTrials
Esophageal Neoplasms Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Biliary Tract Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 3 ClinicalTrials
Carcinoma Phase 2 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Lung Diseases; Neoplasms; Respiratory Tract Diseases; Thoracic Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Adenocarcinoma; Stomach Neoplasms Phase 2 ClinicalTrials
Head and Neck Neoplasms Phase 1/Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary Phase 2/Phase 3 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Thyroid Neoplasms Phase 2 ClinicalTrials
Digestive System Neoplasms; Gastrointestinal Neoplasms; Neoplasms; Stomach Diseases; Stomach Neoplasms Phase 3 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Carcinoma; Gallbladder Neoplasms Phase 2 ClinicalTrials
Pancreatic Neoplasms Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Sarcoma Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Adenocarcinoma; Stomach Neoplasms Phase 3 ClinicalTrials
Head and Neck Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Colorectal Neoplasms Phase 2 ClinicalTrials
Adenocarcinoma Phase 2 ClinicalTrials
Colorectal Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2/Phase 3 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials

Related Entries

UNKNOWN